Is Hair Loss Genetic? What Your DNA Reveals About Baldness

If your father started thinning in his 30s, does that seal your fate? The short answer: genetics account for roughly 80% of your susceptibility to common hair loss, but they do not write the whole story (Nyholt et al., 2003).

Androgenetic alopecia -- the medical name for pattern hair loss -- affects up to 80% of men and 50% of women by age 70 (Ho et al., 2025). It is the single most common cause of hair thinning worldwide, and it runs in families for a reason. Dozens of genes work together to determine when, where, and how fast your hair follicles shrink. Understanding those genes can help you make earlier, smarter decisions about prevention.

How Genetics Drive Hair Loss

Pattern hair loss is not caused by a single "baldness gene." It is polygenic, meaning many genetic variants each contribute a small amount of risk. A landmark UK Biobank study identified 624 independent genetic loci associated with male pattern baldness, confirming that the condition is highly heritable and spread across the entire genome (Yap et al., 2018).

Twin studies put the heritability estimate at about 0.81 -- meaning 81% of the variation in hair loss between individuals can be attributed to genetic differences rather than lifestyle or environment (Nyholt et al., 2003). That is one of the highest heritability estimates for any common trait.

The Androgen Receptor Gene (AR)

The single strongest genetic signal sits on the X chromosome: the androgen receptor gene, or AR (Hillmer et al., 2005). Because men inherit their X chromosome from their mother, this is the scientific basis behind the old saying that "baldness comes from your mother's side." Variants in AR change how sensitive your hair follicles are to dihydrotestosterone (DHT), the hormone that triggers follicle miniaturization.

However, AR is only part of the picture. Genome-wide association studies have found that autosomal (non-sex chromosome) loci also play a major role. Your father's genes matter too.

Chromosome 20p11 and Beyond

The second-strongest risk locus lies on chromosome 20p11, near the genes PAX1 and FOXA2. The variant rs2180439 at this locus showed highly significant association with androgenetic alopecia across both European and Chinese populations (Hillmer et al., 2008; Li et al., 2013). Unlike AR, this region is autosomal, meaning both parents can pass it on.

A large 2017 genome-wide study of more than 70,000 men identified 71 independent susceptibility loci -- 30 of which were completely novel -- collectively explaining 38% of genetic risk (Pirastu et al., 2017). Many of these loci overlap with genes involved in other androgen-related traits, immune function, and even height.

The DHT Mechanism: From Gene to Thinning Hair

Here is what happens biologically:

• The enzyme 5-alpha reductase (encoded by SRD5A1 and SRD5A2) converts testosterone into DHT
• DHT binds to androgen receptors in your scalp hair follicles
• In genetically susceptible follicles, this binding shortens the growth (anagen) phase of the hair cycle
• Over repeated cycles, thick terminal hairs become thin, colorless vellus hairs -- a process called miniaturization
• Eventually the follicle stops producing visible hair altogether

The key insight: DHT levels alone do not determine hair loss. What matters is how your follicles respond to DHT, and that response is largely determined by your AR gene variants and other genetic factors (Kaufman, 2002). This is why two men with identical testosterone levels can have completely different hairlines.

Hair Loss Genetics in Women

Female pattern hair loss (FPHL) affects roughly 50% of women over their lifetime, though it typically presents as diffuse thinning across the crown rather than a receding hairline (Qi & Garza, 2014). The genetics of FPHL are less well understood than the male form. While the AR locus on the X chromosome is strongly associated with male pattern baldness, its role in FPHL appears weaker (Redler et al., 2017).

Research suggests FPHL may involve partially distinct genetic pathways, including genes in the Wnt signaling pathway (such as WNT10A) that regulate hair follicle development and cycling (Redler et al., 2017). Hormonal shifts during menopause also play a significant role, as declining estrogen levels unmask androgen effects on the follicle.

What Your DNA Results Can Tell You

If you have raw DNA data from a service like 23andMe or AncestryDNA, you can check variants linked to hair loss risk. Here are some of the most studied:

• rs6152 (X chromosome, AR gene) -- one of the earliest identified baldness-associated SNPs (Ellis et al., 2001)
• rs2180439 (chromosome 20p11) -- strong risk signal replicated across multiple populations (Hillmer et al., 2008)
• rs7349332 (chromosome 2q35, near WNT10A) -- associated with both male and female pattern hair loss (Heilmann-Heimbach et al., 2017)

Keep in mind that no single SNP is diagnostic. Hair loss risk is the cumulative effect of hundreds of variants, each contributing a small amount. A comprehensive DNA health report can aggregate these signals to estimate your overall genetic predisposition.

What You Can Do About It

Genetics loads the gun, but you still have options:

• Start early. The most effective time to intervene is before significant thinning occurs. If your DNA analysis shows elevated genetic risk, consider talking to a dermatologist proactively.
• FDA-approved treatments. Minoxidil (topical) and finasteride (oral, for men) can slow or partially reverse miniaturization. Finasteride works by blocking 5-alpha reductase, reducing DHT levels by about 70% (Kaufman et al., 1998).
• Monitor changes. Track your hairline with photos every 3 to 6 months. Early detection means more treatment options.
• Optimize scalp health. While genetics dominate, nutritional deficiencies (iron, vitamin D, zinc) can worsen hair shedding independently of androgenetic alopecia (Almohanna et al., 2019).
• Consider pharmacogenomics. Your genetic profile may also affect how you metabolize hair loss medications. Learn how your DNA influences drug response to make more informed treatment decisions.

Key Takeaways

• Androgenetic alopecia is roughly 80% genetic, driven by hundreds of gene variants working together
• The AR gene on the X chromosome is the single strongest risk factor, explaining why maternal family history matters most -- but paternal genes contribute too
• Over 600 genetic loci have been linked to male pattern baldness, with key signals on chromosomes X and 20p11
• Female pattern hair loss has partially overlapping but distinct genetic architecture
• DNA testing cannot predict baldness with certainty, but it can quantify your genetic predisposition and guide earlier intervention
• Treatments like finasteride and minoxidil are most effective when started early, making genetic risk awareness genuinely actionable

Want to see what your DNA says about hair loss, eye color genetics, and hundreds of other traits? Upload your raw DNA data to GenomeInsight for a comprehensive, privacy-first health report. Already exploring your results? Check out our full blog for deep dives into the genetics behind the traits that matter to you, or subscribe to our newsletter for the latest in genomic health.

References

Almohanna, H. M., Ahmed, A. A., Tsatalis, J. P., & Tosti, A. (2019). The role of vitamins and minerals in hair loss: A review. Dermatology and Therapy, 9(1), 51-70. https://doi.org/10.1007/s13555-018-0278-6

Ellis, J. A., Stebbing, M., & Harrap, S. B. (2001). Polymorphism of the androgen receptor gene is associated with male pattern baldness. Journal of Investigative Dermatology, 116(3), 452-455. https://doi.org/10.1046/j.1523-1747.2001.01261.x

Heilmann-Heimbach, S., Hochfeld, L. M., Paus, R., & Nothen, M. M. (2017). Hunting the genes in male-pattern alopecia: How important are they, how close are we and what will they tell us? Experimental Dermatology, 25(4), 251-257. https://doi.org/10.1111/exd.12965

Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freudenberg, J., Brockschmidt, F. F., ... & Nothen, M. M. (2005). Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American Journal of Human Genetics, 77(1), 140-148. https://doi.org/10.1086/431425

Hillmer, A. M., Brockschmidt, F. F., Hanneken, S., Eigelshoven, S., Steffens, M., Flaquer, A., ... & Nothen, M. M. (2008). Susceptibility variants for male-pattern baldness on chromosome 20p11. Nature Genetics, 40(11), 1279-1281. https://doi.org/10.1038/ng.228

Ho, C. H., Nguyen, A., & Zheng, M. (2025). Epidemiological landscape of androgenetic alopecia in the US: An All of Us cross-sectional study. PLOS ONE, 20(2), e0319040. https://doi.org/10.1371/journal.pone.0319040

Kaufman, K. D. (2002). Androgens and alopecia. Molecular and Cellular Endocrinology, 198(1-2), 89-95. https://doi.org/10.1016/S0303-7207(02)00372-6

Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., ... & Gormley, G. J. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 39(4), 578-589. https://doi.org/10.1016/S0190-9622(98)70007-6

Li, R., Brockschmidt, F. F., Kiefer, A. K., Stefansson, H., Nyholt, D. R., Song, K., ... & Heilmann, S. (2013). Genetic variants at 20p11 confer risk to androgenetic alopecia in the Chinese Han population. PLOS ONE, 8(8), e71771. https://doi.org/10.1371/journal.pone.0071771

Nyholt, D. R., Gillespie, N. A., Heath, A. C., & Martin, N. G. (2003). Genetic basis of male pattern baldness. Journal of Investigative Dermatology, 121(6), 1561-1564. https://doi.org/10.1111/j.1523-1747.2003.12615.x

Pirastu, N., Joshi, P. K., de Vries, P. S., McEvoy, B. P., ... & Wilson, J. F. (2017). GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. Nature Communications, 8, 1584. https://doi.org/10.1038/s41467-017-01490-8

Qi, J., & Garza, L. A. (2014). An overview of alopecias. Cold Spring Harbor Perspectives in Medicine, 4(3), a013615. https://doi.org/10.1101/cshperspect.a013615

Redler, S., Messenger, A. G., & Betz, R. C. (2017). Genetics and other factors in the aetiology of female pattern hair loss. Experimental Dermatology, 26(6), 510-517. https://doi.org/10.1111/exd.13373

Yap, C. X., Sidorenko, J., Wu, Y., Kemper, K. E., Yang, J., Wray, N. R., ... & Visscher, P. M. (2018). Dissection of genetic variation and evidence for pleiotropy in male pattern baldness. Nature Communications, 9, 5407. https://doi.org/10.1038/s41467-018-07862-y

---

Related Reading

• polygenic risk scores
• hypertension genetics
• genetic testing